Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F H Messerli

Showing results (201-210 of 338) with videos related to

Pageof 34
Sort By:
Journal of Hypertension|June 1, 1986
Norepinephrine-induced hypertension in Guillain Barré syndromeH O Ventura, F H Messerli, R E Barron
Klinische Wochenschrift|July 15, 1978
Responsiveness of plasma aldosterone: dependency upon basal secretory activityF H Messerli, P Weidmann, R DeChâtel, et al.
European Heart Journal|February 1, 1996
Fitness in the fit: does physical conditioning affect cardiovascular risk factors in middle-aged marathon runners?R G Ketelhut, K Ketelhut, F H Messerli, et al.
The American Journal of Cardiology|June 5, 1989
Hemodynamic and humoral effects of intravenous dilevalol in patients with moderate hypertensionE Grossman, F H Messerli, S Oren, et al.
Journal of Human Hypertension|August 14, 1998
Regression of LVH or improved prognosis (or both): what is the question?G Y Lip, C Lydakis, J Zarifis, et al.
JAMA|December 5, 1990
Glomerular hyperfiltration indicates early target organ damage in essential hypertensionR E Schmieder, F H Messerli, G Garavaglia, et al.
The American Journal of Cardiology|March 15, 1997
Cardiovascular effects of a trandolapril/verapamil combination in patients with mild to moderate essential hypertensionF C Aepfelbacher, F H Messerli, E Nunez, et al.
Cardiology Clinics|November 1, 1988
High blood pressure: side effects of drugs, poisons, and foodS Oren, E Grossman, F H Messerli, et al.
Medicina|January 1, 1988
[Risks in the development of hypertension]R E Schmieder, G Garavaglia, H Ruddel, et al.
Journal of Internal Medicine|August 26, 2009
Cardioprotection with beta-blockers: myths, facts and Pascal's wagerF H Messerli, S Bangalore, S S Yao, et al.
Pageof 34

Showing results (201-210 of 338) with videos related to

Sort By:
Pageof 34
Journal of Hypertension|June 1, 1986
Norepinephrine-induced hypertension in Guillain Barré syndromeH O Ventura, F H Messerli, R E Barron
Klinische Wochenschrift|July 15, 1978
Responsiveness of plasma aldosterone: dependency upon basal secretory activityF H Messerli, P Weidmann, R DeChâtel, et al.
European Heart Journal|February 1, 1996
Fitness in the fit: does physical conditioning affect cardiovascular risk factors in middle-aged marathon runners?R G Ketelhut, K Ketelhut, F H Messerli, et al.
The American Journal of Cardiology|June 5, 1989
Hemodynamic and humoral effects of intravenous dilevalol in patients with moderate hypertensionE Grossman, F H Messerli, S Oren, et al.
Journal of Human Hypertension|August 14, 1998
Regression of LVH or improved prognosis (or both): what is the question?G Y Lip, C Lydakis, J Zarifis, et al.
JAMA|December 5, 1990
Glomerular hyperfiltration indicates early target organ damage in essential hypertensionR E Schmieder, F H Messerli, G Garavaglia, et al.
The American Journal of Cardiology|March 15, 1997
Cardiovascular effects of a trandolapril/verapamil combination in patients with mild to moderate essential hypertensionF C Aepfelbacher, F H Messerli, E Nunez, et al.
Cardiology Clinics|November 1, 1988
High blood pressure: side effects of drugs, poisons, and foodS Oren, E Grossman, F H Messerli, et al.
Medicina|January 1, 1988
[Risks in the development of hypertension]R E Schmieder, G Garavaglia, H Ruddel, et al.
Journal of Internal Medicine|August 26, 2009
Cardioprotection with beta-blockers: myths, facts and Pascal's wagerF H Messerli, S Bangalore, S S Yao, et al.
Pageof 34